EUVIMEDOpdag EUVIMED
ValidierungsstudieOpen access · CC BY 4.0

A mobile interactive cognitive self-assessment scale for screening cognitive impairment due to Alzheimer’s disease

Kexin Xie, Juan Huang, Ting Chen, Dan Li, Tianxinyu Xia, Min Chu, Yue Cui, Mei Tang, Dantao Peng, Jingtong Wang, Jianling Liu, Xiaojuan Chen and 6 more

Age and Ageing · 2025

DOI: 10.1093/ageing/afae293 ↗

At a glance

Validierungsstudie in Age and Ageing, 2025. Written by Kexin Xie and 17 co-authors. Institution: Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. Major MEDLINE topics: Alzheimer Disease, Cognitive Dysfunction, Cognition, Mobile Applications. Cited 2 times so far (Crossref); 32 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Beijing Municipal Science and Technology Committee.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

A mobile cognition scale for community screening in cognitive impairment with rigorous validation is in paucity. We aimed to develop a digital scale that overcame low education for community screening for mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) and AD.

Methods

A mobile cognitive self-assessment scale (CogSAS) was designed through the Delphi process, which is feasible for the older population with low education. In Phase 1, 518 clinically diagnosed participants were subjected to optimise the items. In Phase 2, the scale was validated in 358 participants with cognitively unimpaired and 396 participants of clinically diagnosed MCI and dementia for reliability, validity and diagnostic accuracy. In Phase 3, specificity and sensitivity were tested for biologically diagnosed participants of 38 with cognitively unimpaired and 45 with MCI and dementia due to AD according to the amyloid, tau, neurodegeneration classification system.

Results

The CogSAS was a three-task mobile scale testing memory and executive function. In Phase 2, the internal consistency was 0.81, and the test–retest reliability was 0.82. The construct validity was 0.74, and the criterion validity was 0.77. The sensitivity and specificity for discriminating clinically diagnosed participants with MCI and dementia from cognitively unimpaired were 0.90 and 0.67, respectively. For discriminating biologically diagnosed MCI and dementia due to AD from cognitively unimpaired, the sensitivity and specificity were 1.00 and 0.78, respectively.

Conclusions

The CogSAS has good reliability, validity and feasibility, showing a high sensitivity and specificity both in the community and the clinic, identifying biologically diagnosed MCI and dementia due to AD.

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionCognitionMobile ApplicationsNeuropsychological TestsHumansMaleFemaleAgedReproducibility of ResultsAged, 80 and overDelphi TechniquePredictive Value of TestsMiddle AgedExecutive FunctionFeasibility Studies

Author keywords

Alzheimer’s diseasecognitive impairmentdiagnostic accuracymobile cognitive assessment scaleolder peoplescreening measurevalidation

Authors and institutions

  • Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Department of Neurology, FuXing Hospital, Capital Medical University, Beijing, China.
  • Institute for Smart Ageing, Beijing Academy of Science and Technology, Beijing, China.
  • Department of Geriatric Medicine, Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing, China.
  • Department of Neurology, China-Japan Friendship Hospital, Ministry of Health, Beijing, China.
  • Department of Gerontology, Peking University People's Hospital, Beijing, China.

Funding

  • National Natural Science Foundation of China
  • Beijing Municipal Science and Technology Committee

Cite

APA

Xie, K., Huang, J., Chen, T., Li, D., Xia, T., Chu, M., Cui, Y., Tang, M., Peng, D., Wang, J., Liu, J., Chen, X., Cui, W., Liu, L., Wang, Y., Liu, J., Li, F., & Wu, L. (2025). A mobile interactive cognitive self-assessment scale for screening cognitive impairment due to Alzheimer’s disease. Age and Ageing. https://doi.org/10.1093/ageing/afae293

Vancouver

Xie K, Huang J, Chen T, Li D, Xia T, Chu M, et al. A mobile interactive cognitive self-assessment scale for screening cognitive impairment due to Alzheimer’s disease. Age and Ageing. 2025. doi:10.1093/ageing/afae293

BibTeX
@article{Xie2025,
  author = {Xie, Kexin and Huang, Juan and Chen, Ting and Li, Dan and Xia, Tianxinyu and Chu, Min and Cui, Yue and Tang, Mei and Peng, Dantao and Wang, Jingtong and Liu, Jianling and Chen, Xiaojuan and Cui, Weiwei and Liu, Li and Wang, Yingtao and Liu, Jianbing and Li, Fang and Wu, Liyong},
  title = {A mobile interactive cognitive self-assessment scale for screening cognitive impairment due to Alzheimer’s disease},
  journal = {Age and Ageing},
  year = {2025},
  doi = {10.1093/ageing/afae293}
}
Start for free →